131 results on '"Newsome, Simon"'
Search Results
2. End points in clinical trials in diffuse large B-cell lymphoma: time for more dialogue?
3. Predictors and Mechanisms of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
4. Cardiovascular magnetic resonance predictors of heart failure in hypertrophic cardiomyopathy: the role of myocardial replacement fibrosis and the microcirculation
5. Microvascular Dysfunction in Dilated Cardiomyopathy: A Quantitative Stress Perfusion Cardiovascular Magnetic Resonance Study
6. Outcome in Dilated Cardiomyopathy Related to the Extent, Location, and Pattern of Late Gadolinium Enhancement
7. Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial
8. Absence of Myocardial Fibrosis Predicts Favorable Long-Term Survival in New-Onset Heart Failure: A Cardiovascular Magnetic Resonance Study
9. Data Resource Profile: The UK Cystic Fibrosis Registry
10. Osteoprotegerin and Myocardial Fibrosis in Patients with Aortic Stenosis
11. Precision Phenotyping of Dilated Cardiomyopathy Using Multidimensional Data
12. Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
13. Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
14. Prognostic significance of nonischaemic myocardial fibrosis in patients with normal left ventricular volumes and ejection-fraction
15. Tisagenlecleucel Vs Standard of Care As Second-Line Therapy of Primary Refractory or Relapsed Aggressive B-Cell Non-Hodgkin Lymphoma: Analysis of the Phase III Belinda Study
16. Using Negative Control Outcomes and Difference-in-Differences Analysis to Estimate Treatment Effects in an Entirely Treated Cohort: The Effect of Ivacaftor in Cystic Fibrosis
17. Tisagenlecleucel Vs Standard of Care As Second-Line Therapy of Primary Refractory or Relapsed Aggressive B-Cell Non-Hodgkin Lymphoma: Analysis of the Phase III Belinda Study
18. Abstract CT162: The phase 1b PORTIA study: Safety and efficacy of tisagenlecleucel plus pembrolizumab in patients with relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL)
19. Bianca: Phase II, single-arm, global trial to determine efficacy and safety of tisagenlecleucel in pediatric/young adult (YA) patients (Pts) with relapsed/refractory B-cell non-Hodgkin lymphoma (R/R B-NHL).
20. Predictors of left ventricular remodelling in patients with dilated cardiomyopathy – a cardiovascular magnetic resonance study
21. Using Negative Control Outcomes and Difference-in-Differences Analysis to Estimate Treatment Effects in an Entirely Treated Cohort: The Effect of Ivacaftor in Cystic Fibrosis.
22. A model based on clinical parameters to identify myocardial late gadolinium enhancement by magnetic resonance in patients with aortic stenosis: An observational study
23. Sex‐ and age‐based differences in the natural history and outcome of dilated cardiomyopathy
24. Absence of Myocardial Fibrosis Predicts Favorable Long-Term Survival in New-Onset Heart Failure
25. Outcome in dilated cardiomyopathy related to the extent, location and pattern of late gadolinium enhancement
26. Estimating long-term treatment effects in observational data: A comparison of the performance of different methods under real-world uncertainty
27. Phenotype and Clinical Outcomes of Titin Cardiomyopathy
28. External Aortic Root Support to Prevent Aortic Dilatation in Patients With Marfan Syndrome
29. Sex‐ and age‐based differences in the natural history and outcome of dilated cardiomyopathy
30. D Perfusion abnormalities in hypertrophic cardiomyopathy: mechanisms and prognostic importance
31. Impact of known or new-onset atrial fibrillation on 2-year cardiovascular event rate in patients with acute coronary syndromes: results from the prospective EPICOR Registry
32. DEFINING THE RELATIONSHIP BETWEEN THE EXTENT OF MID-WALL LATE GADOLINIUM ENHANCEMENT AND ADVERSE HEART FAILURE EVENTS IN PATIENTS WITH DILATED CARDIOMYOPATHY
33. PROGNOSTIC SIGNIFICANCE OF NON-ISCHAEMIC MYOCARDIAL FIBROSIS IN PATIENTS WITH NORMAL LV SIZE AND FUNCTION: A LARGE CMR REGISTRY STUDY
34. SEX DIFFERENCES IN THE NATURAL HISTORY AND OUTCOME OF DILATED CARDIOMYOPATHY
35. Data Resource Profile:The UK Cystic Fibrosis Registry
36. Predicting two-year mortality from discharge after acute coronary syndrome: An internationally-based risk score
37. Lipoprotein(a) in patients with aortic stenosis: Insights from cardiovascular magnetic resonance
38. 127 Relationship between plasma concentrations of b-type natriuretic peptide and exercise capacity in hypertrophic cardiomyopathy
39. 125 Evaluation of titin cardiomyopathy in patients with dilated cardiomyopathy reveals a blunted hypertrophic response, an early arrhythmic risk and a significant interaction with alcohol
40. Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction
41. Truncating Variants in Titin Independently Predict Early Arrhythmias in Patients With Dilated Cardiomyopathy
42. 002 Sudden cardiac death risk stratification in patients with mild dilated cardiomyopathy
43. INTEGRATED ANALYSIS OF THE CLINICAL MANIFESTATIONS AND PHENOTYPIC DRIVERS OF TITIN CARDIOMYOPATHY
44. 43 Euroscore II and STS Risk Model Scores in Aortic Stenosis: Can We Rely on Them?
45. 142 Effects of Truncating Variants in Titin on Cardiac Phenotype and Left Ventricular Remodelling in Dilated Cardiomyopathy
46. 143 Clinical and Genetic Characteristics of Familial Dilated Cardiomyopathy in a Large UK Prospective Cohort: Abstract 143 Table 1
47. Predicting two-year mortality from discharge after acute coronary syndrome: An internationally-based risk score
48. Impact of known or new-onset atrial fibrillation on 2-year cardiovascular event rate in patients with acute coronary syndromes: results from the prospective EPICOR Registry
49. Evaluating the significance of left ventricular midwall fibrosis detected by late gadolinium enhancement imaging on left ventricular functional remodelling in dilated cardiomyopathy
50. A simple clinical model to predict presence of myocardial fibrosis in patients with aortic stenosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.